Does Pennsylvania Medicaid cover Wegovy and Zepbound in 2026?

No, not since Jan 1, 2026. As of Oct 23, 2026, Pennsylvania Medicaid no longer covers GLP-1 drugs for obesity alone.

What this covers

Coverage of GLP-1 drugs for obesity alone under Pennsylvania’s fee-for-service Medicaid drug rules, as the state publishes them. The plan decides each request.

Pennsylvania’s rule

In plain words

Coverage ended in 2026

Coverage for overweight and obesity ended Jan 1, 2026; other conditions with prior authorization.

Source

PA DHS Medical Assistance Bulletin, Nov 24, 2025 (opens in new tab). Checked Oct 23, 2026.

Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization. Social Security Act §1927(d)(1)(A) and (d)(2)(A), 42 U.S.C. 1396r-8(d) (opens in new tab).

What changed

Questions this page answers

Does Pennsylvania Medicaid cover Wegovy and Zepbound for weight loss?

No, not since Jan 1, 2026. As of Oct 23, 2026, Pennsylvania Medicaid no longer covers GLP-1 drugs for obesity alone. Coverage for overweight and obesity ended Jan 1, 2026; other conditions with prior authorization.

Has Pennsylvania’s rule changed recently?

Jan 1, 2026: Pennsylvania Medical Assistance stopped covering GLP-1s for overweight and obesity.

Where does this information come from?

From PA DHS Medical Assistance Bulletin, Nov 24, 2025, read on Oct 23, 2026. Federal Medicaid law lets a state exclude these drugs only “when used for anorexia, weight loss, or weight gain”; their use for type 2 diabetes is not on that list, though a state may require prior authorization.

Kymata Health reads each state’s own Medicaid documents. See every state on the map.

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.